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AbstrACt
Introduction In Scotland, the incidence of breast cancer 
is predicted to rise significantly in the next few decades 
and while there are measures to support reductions in 
morbidity and mortality, the breast cancer community 
is currently exploring preventative opportunities 
including supporting weight management programmes 
in postmenopausal women. This study aims to assess 
the effectiveness and cost-effectiveness of a theory-
based, community delivered, minimal contact, weight 
management (diet, physical activity and behaviour change 
techniques) programme (ActWELL) in women with a body 
mass index (BMI) >25 kg/m2 attending routine breast 
cancer screening appointments.
Methods and analysis The study will be a four-centre, 
1:1 parallel group randomised controlled trial of a 
12-month weight management intervention initiated in 
breast cancer screening centres, delivered by trained 
Breast Cancer Now lifestyle coaches in community 
settings. The intervention programme involves two 
intervention meetings with coaches plus (up to) nine 
telephone contacts over 12 months. The programme 
will focus on personalised diet (including alcoholic and 
sugary drinks) and physical activity habits. Behaviour 
change techniques include self-monitoring, goal setting, 
implementation intentions, action and coping plans. 
The study has a sample size of 414 women with a BMI 
>25 kg/m2 attending routine National Health Service 
breast cancer screening appointments. Measures will 
be taken at baseline, 12 weeks and at 12-month follow-
up, complemented by qualitative interviews exploring 
perceived acceptability and impact on habitual behaviours. 
The two co-primary outcomes are mean change in 
measured body weight and change in physical activity 
between groups to 12 months. Secondary outcomes are 
changes in eating habits, alcohol intake, sedentary time, 
quality of life, waist circumference, lipid, haemoglobin A1c 
and insulin profiles, blood pressure and cost-effectiveness 
of the intervention.
Ethics and dissemination The protocol has been 
approved by East of Scotland Research Ethics Committee 
(17/ES/0073). All participants provide written informed 
consent. Dissemination will be through peer-reviewed 
publication and conference presentations.
trial registration number ISRCTN11057518; Pre-results.
IntroduCtIon 
Breast cancer accounted for 14.5% of all 
cancer diagnoses in Scotland in 2014 and 
accounts for 28% of female cancer cases.1 
Incidence is increasing and current predic-
tions from ISD (Scottish Government) 
suggest a rise by 27.5% between 2008–2012 
and 2023–2027.2 
While many factors are implicated in aeti-
ology (genetics, reproductive history, hormone 
use), current estimates suggest that 38% of 
breast cancers in postmenopausal women 
in the UK are related to physical inactivity, 
alcohol consumption and body fatness.3 There 
is consistent evidence that being overweight or 
obese throughout adulthood increases the risk 
of postmenopausal breast cancer.4
In addition, gaining weight in adult 
life is a strong predictor of breast cancer 
(especially in women who have not taken 
hormone replacement therapy).5 Ahn 
et al reported that at any body mass index 
(BMI), increased weight in adult life is asso-
ciated with greater risk of breast cancer and 
a gain of 2–10 kg after the age of 50 (eg, 
postmenopausal) is associated with a 30% 
strengths and limitations of this study
 ► This work has the potential to provide routine sup-
port for weight management for women aged over 
50 years.
 ► Multicentre, randomised controlled design.
 ► Novel approach to deliver weight management by 
trained volunteers in community locations.
 ► The study has a large potential reach with around 
73% of ALL women of this age group attending ap-
pointments including high numbers from disadvan-
taged backgrounds.
 ► The intervention will not be readily accessible for 
women who do not accept screening appointments.
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increase in breast cancer risk.6 Findings from the Euro-
pean Prospective Investigation into Cancer and Nutrition 
(EPIC) study have also demonstrated that high weight 
gain in middle adulthood increases the risk of breast 
cancer.7 In the Women’s Health Initiative, Neuhouser 
et al8 reported that postmenopausal women with a 
BMI <25 kg/m2 at baseline who gained >5 kg of body 
weight during the follow-up period (median 13 years) 
had a 36% increase risk of developing breast cancer.
Lifestyles and weight management are also related to risk 
reduction. Women meeting at least five of the World Cancer 
Research Fund prevention guidelines for lifestyle show a 
60% lower risk for breast cancer compared with women 
meeting none of the guidelines9 and a recent systematic 
review reported that high versus low adherence to cancer 
prevention guidelines was associated with consistent reduc-
tions in breast cancer incidence.10 Data from audits of 
bariatric surgery show that large weight losses are associated 
with large decreases in female cancers.11 One recent North 
American study of 22 198 people 3.5 years after bariatric 
surgery reported reductions in postmenopausal breast 
cancer of 42%.12 In addition, moderating weight gain in 
adult life through caloric adjustment and being physically 
active is likely to be of benefit for reduction in other cancers 
related to these behaviours13 as well as other non-commu-
nicable diseases.14 15
Most (73%) Scottish women aged 50–70 years accept invi-
tations to attend the routine NHS Scottish Breast Screening 
Programme (NHSSBSP) and over 175 000 women attend 
each year.16 In addition, women aged over 70 years are able 
to attend through self-referral. The NHSSBSP therefore 
provides a unique opportunity to endorse a weight manage-
ment intervention. However, a greater understanding of 
the benefits, costs, acceptability and impacts are needed to 
examine whether a NHSSBSP-initiated intervention can be 
effective and cost-efficient.
In 2007, Fisher et al17 reported that most women 
attending breast screening clinics are interested in 
receiving lifestyle advice, and an updated paper reporting 
the view of 1803 women shows overwhelming support for 
receiving interventions through this setting.18 However, a 
review published in 201319 reported that while the impor-
tance of weight management in breast and colorectal 
cancer prevention is widely recognised, there is little 
evidence that lifestyle is discussed within cancer screening 
settings. It was also noted that the lack of advocacy about 
health behaviour change may endorse poor health 
behaviours by creating a ‘health certificate effect'. This 
issue may be particularly relevant for body weight, where 
a lack of guidance to visibly obese patients may imply a 
lack of medical concern. The cancer research ‘gap anal-
ysis’ reviews by Breast Cancer Campaign20 21 highlighted 
the role of breast screening programmes as an opportu-
nity for promoting cancer prevention activities, but noted 
the challenge of finding ways to support and facilitate 
women to achieve healthy ways of life.
In Scotland, the breast cancer community (govern-
ment, charities and health professionals) is currently 
exploring innovative and sustainable preventative oppor-
tunities including supporting weight management 
programmes. The Scottish Health Survey22 has reported 
that 72% of women aged 55–74 years have a BMI >25 kg/
m2 (76% in women living in areas of higher deprivation). 
Furthermore, 42% of women do not achieve the recom-
mendation of 150 min of physical activity per week, and 
this proportion increases with age. The National Insti-
tute of Clinical Excellence23 recommend that lifestyle 
weight management programmes are multicomponent 
and aim to reduce a person’s energy intake and help 
them to be more physically active by changing behaviour. 
However, access to such National Health Service (NHS) 
programmes is limited and commercial programmes 
have cost implications for low-income adults.
It is recognised that partnerships between the NHS 
and the voluntary sector offer significant value for money 
and the potential for greater ‘reach’ of interventions 
into community settings. The recent Lancet series on 
obesity highlighted that, despite government efforts to 
reduce the prevalence of obesity, these approaches are 
insufficient to help adults who are currently overweight 
or obese.24 Innovative strategies beyond those currently 
delivered by health professionals are needed to increase 
capacity of delivery of weight management programmes.
Community lifestyle interventions initiated in the breast 
cancer screening setting are a largely unexplored area, 
although repeated triennial appointments offer unique 
opportunities for initiation and re-enforcement.25 This 
setting also provides an opportunity to engage with women 
from areas of higher deprivation (63%, 71% and 76% of 
women from Scottish Index of Multiple Deprivation (SIMD) 
1, 2, 3 quintiles, respectively attend for screening).26
The ActWELL feasibility study demonstrated that 
recruitment, retention, indicative results and participant 
acceptability merited a full randomised controlled trial to 
test the long-term impact of the intervention. In addition, 
31% of participants recruited were from the lowest two 
quintiles of deprivation27 indicating significant potential 
to reach women from higher rates of social deprivation 
who also tend to be more obese.
Feedback from screening centre users showed while many 
were aware of lifestyle issues in relation to diabetes and 
cardiovascular disease, information about lifestyle and breast 
cancer was new and considered ‘motivating’ if the focus was 
on positive ways to help support behaviour change.28
The current study is designed to assess the effectiveness 
of a community-based, personalised, minimal contact 
weight management programme in women with a 
BMI >25 kg/m2 attending routine breast cancer screening 
clinics. The intervention programme is a collaboration 
between the charity Breast Cancer Now (BCN), NHSSBSP, 
local authority leisure centres and academic partners. 
This work is the first time that a cancer charity has offered 
volunteer capacity for cancer prevention action on weight 
management and offers significant potential to address 
gaps in public health efforts. The design is pragmatic to 
increase the relevance of the findings to policymakers, 
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women eligible for breast screening and health profes-
sionals (see online supplementary appendix 1).
The study aims to assess the effectiveness and cost-effec-
tiveness of a theory-based, community delivered, minimal 
contact, weight management (diet, physical activity and 
behaviour change techniques) programme (ActWELL) 
in women with a BMI >25 kg/m2 attending routine breast 
cancer screening clinics.
MEthods And AnAlysIs
trial design and setting
The study will be a four-centre, 1:1 parallel-arm, randomised 
controlled trial of a 12-month, weight management inter-
vention. The participants will be randomly allocated to 
one of two groups: (1) standard care with health infor-
mation leaflet or (2) experimental group who receive 
the ActWELL intervention. Potential participants will be 
introduced to the study while attending a routine NHS 
breast cancer screening appointment (static and mobile 
screening units) in Scotland. The study participant flow is 
presented in figure 1.
All trial measurements will be undertaken by trained 
research nurses at baseline, 12 weeks and 12 months 
within the NHS Clinical Research Centres in the areas 
served by the breast screening sites.
The intervention is delivered and supported by BCN 
volunteers who have undergone 2 days bespoke training 
on the intervention. The face-to-face intervention 
Figure 1 Study flow chart. NHSSBSP, NHS Scottish Breast Screening Programme; PIS, Participant Information Sheet.  o
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communications are delivered within local authority 
run leisure centres (or other appropriate community 
locations).
Participants
All attendees at routine NHS breast screening appoint-
ments will be advised about the study by NHSSBSP staff 
in writing and verbally. On checking in at the clinic 
women will be given a brief study information leaflet 
by the receptionist. During their visit the mammogra-
pher will briefly (approximately 30 s) mention the study 
verbally. If they are agreeable to a researcher making 
contact with them, women will be invited to leave their 
details on a contact card (telephone/email/postcode), 
which they can place in a study box in the reception 
area. A pop up banner, or poster, will also be displayed 
in the breast screening clinic or mobile van to further 
highlight the study and how to contact the research 
team. All NHS screening staff will be provided with 
training which introduces the aims of the study, why the 
trial is designed the way it is, the importance of their 
role, how to minimise the time taken to introduce the 
study and how to answer common questions. Within 
each site, a team ‘champion’ will be identified from 
within the NHSSBSP staff to encourage colleagues and 
coordinate recruitment efforts.
Research staff will contact women leaving contact cards 
within 2 weeks and assess study eligibility.
Inclusion criteria
 ► Attending, or invited to attend, routine breast 
screening clinics (not recall clinics).
 ► Measured BMI >25 kg/m2.
 ► Age 50–70 years.
Exclusion criteria
 ► Currently undergoing treatment for any malignant 
condition (excluding basal or squamous cell skin 
cancers).
 ► Reported contraindication to physical activity (eg, 
recent surgery).
 ► Reported contraindication to weight loss (eg, currently 
following a recovery programme for weight gain).
 ► On a specialised diet, for example, gluten free.
 ► Diagnosis of type 1 diabetes.
 ► Current use of insulin.
 ► No telephone contact.
 ► Unable to consent.
Participants who are considered eligible will be invited 
to attend their local research centre to provide informed 
consent before commencing baseline measures.
Participants found to be ineligible to take part, either 
on telephone screening or at a baseline visit, will be 
thanked for their time and will be offered, by post or 
email, lifestyle and cancer prevention information and/
or information on local leisure facilities applicable to 
them. Where possible, this will also apply to women who 
have expressed an interest (eg, left a completed card) but 
who have not been selected to take part in the trial due 
to the volume of people that can be seen by the research 
team. In the event of very large numbers of cards being 
returned, it may not be possible to contact all women and 
this is made clear in the brief information leaflet.
randomisation
Participants will be randomised centrally at a 1:1 ratio into 
the intervention or usual care groups using the web-based 
TRuST system designed by Tayside Clinical Trials Unit 
(TCTU). Randomisation will be stratified by site and 
minimised by socioeconomic status based on SIMD29 (two 
groups: SIMD 1 or 2; SIMD ≥3).
In addition, a subgroup comprising 146 women (73 
from each group) will be randomly allocated by the 
TRuST system to receive an activPAL monitor (acceler-
ometer; PAL Technologies, Glasgow, UK) as an objective 
measure of physical activity. This number has been identi-
fied to meet statistical power (see below).
Usual care group
Following the end of their baseline measures, participants 
will receive a cancer prevention leaflet.30 The study admin-
istrator will then notify participants of their randomisa-
tion by letter. On completion of their 12-month follow-up 
visit, women will be offered a single personalised coaching 
session and the ActWELL intervention booklet.
Intervention group
Following the end of their baseline measures, partici-
pants will receive a cancer prevention leaflet.30 The study 
administrator will then notify participants of their rando-
misation by letter. The BCN volunteer coordinator will 
allocate a BCN lifestyle coach to the participant. The 
lifestyle coach will contact the participant to arrange an 
appointment for their first face-to-face visit.
blinding
The study team will be blind to the participants’ group 
allocation until completion of the primary outcome anal-
ysis. Exceptions are the trial manager, study administrator, 
lifestyle coaches and participants who cannot be blinded 
owing to the nature of the intervention.
Intervention
Initial work focused on optimising the intervention to 
scale up the previous prototype for a 12-month follow-up 
period. This was developed from the original feasibility 
study protocol and using feedback obtained from study 
participants and lifestyle coaches. Later feedback came 
from our recent research study offering a weight manage-
ment lifestyle intervention to women attending family 
history clinics31 and our newly formed ActWELL public 
advisory team. The proposed study builds on existing 
behaviour change models,32 particularly the COM-B 
model.33 Thus, the intervention aims to incorporate capa-
bility for effective lifestyle change combined with opportu-
nities for greater physical activity through an emphasis on 
walking initiatives and other community facilities (using 
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taxonomy-derived effective behaviour change tech-
niques34) and increased motivation for weight manage-
ment (through awareness raising within the teachable 
moment setting).
In addition, four formative qualitative focus groups 
with individuals in the target population will be held to 
obtain feedback on the prospective 12-month interven-
tion including refinements on alcohol messaging.
Intervention content
The initial part of the intervention (1–3 months) will 
focus on helping achieve 7% of body weight loss (consis-
tent with the lifestyle intervention in the highly effective 
Diabetes Prevention Programme35) and the remaining 
months will also combine techniques for weight loss 
maintenance (WLM) by addressing both caloric intake 
and energy expenditure.
Behavioural change techniques (BCT) include goal 
setting, implementation intentions, self-monitoring of 
body weight and feedback. The latter may be particu-
larly important for WLM. This part of the intervention 
will take a habit formation-based approach using the ‘Ten 
Top Tips’ shown to be successful for WLM over a 2-year 
period.36 Social support will be encouraged throughout 
the 12 months through regular coach contact and 
encouragement to share the intervention with a friend/
buddy. The initial introduction to the leisure centre will 
also provide an introduction to locally available exercise 
facilities and classes.
Tailored personalised advice is a key component of all 
aspects of the intervention. Motivational interviewing 
about weight loss will be undertaken to identify partici-
pant ambivalence and perceived personal advantages to 
weight management.
The caloric prescription will be based on 600 kcal below 
that required for weight maintenance (calculated using 
the equations for basal metabolic rate according to 
gender, age and body weight).
Food and drink choices will be based on information 
obtained from current eating habits obtained through 
a 24 hour recall questionnaire to guide personalised 
advice on food frequency, portion sizes and foods to 
limit. Participant agreed goals (and implementation 
intentions) will be used for one specific food or drinking 
habit and this will be self-monitored with personalised 
feedback provided.
Physical activity dose: all participants will undertake the 
Scottish Physical Activity Screening Questionnaire37 by 
the coach as an indicator of current activity levels to help 
guide the communications about walking plans and sign-
post other activities (including those offered in the local 
leisure centres). Participant agreed pedometer goals (and 
implementation intentions) will be used for habitual 
walking and this will be self-monitored with personalised 
feedback provided. Participants will be supported to 
gradually increase physical activity towards accumulating 
at least 150 min of moderate intensity physical activity 
per week and then, where appropriate, towards 300 min 
per week (based on Scottish Intercollegiate Guidelines 
Network38 guidance on weight management).
A detailed description of each intervention visit and 
telephone calls are provided in online supplementary 
appendix 2.
Intervention delivery: there will be two face-to-face inter-
vention meetings (one of 60 min and one of 45 min). 
Over a 12-month period there will be up to nine further 
contacts by telephone. The intervention programme will 
be delivered by BCN volunteers who have received the 
training programme to become lifestyle coaches.
Intervention fidelity: we will undertake independent anal-
ysis of fidelity to the intervention. Fidelity of programme 
delivery and content will be assessed by audio-recording 
and transcription from a purposeful sample of approxi-
mately 10% of ActWELL lifestyle coaches including face-
to-face interactions and telephone contacts at each site. 
A researcher independent from the intervention delivery 
will analyse the transcripts and evaluate the proportion of 
points covered in each session relative to those described 
in the intervention protocol. Time for implementation 
procedures will be recorded by the lifestyle coaches.
outcome measures
A full list of measurable outcomes and sources39–42 is 
presented in table 1.
Data collection will occur at baseline, 12 weeks and 12 
months. Data will be collected by the blinded research 
nurses from the clinical research centres in each loca-
tion (trained on the study protocol) at baseline and 12 
months, and over the telephone at 3 months, and entered 
directly onto study case report forms and questionnaires. 
Detailed Standard Operating Procedures will be provided 
on each aspect of the protocol to ensure consistent meth-
odology is used by all staff.
At baseline, along with the collection of demographic 
and background (eg, menopausal and smoking status) 
data by questionnaire, any contraindications to physical 
activity will also be assessed using the PAR-Q physical 
activity readiness questionnaire.43 44 Where required, and 
in all women aged 70 years, participants will be asked 
to seek advice from their general practitioner before 
becoming more physically active. Height will also be 
measured to the nearest 1 mm using a calibrated stadiom-
eter, with shoes removed, in order to determine BMI and 
confirm eligibility.
Co-primary outcomes
Co-primary outcomes will be change in body weight and 
change in physical activity by 12 months. Both will be 
measured as the mean difference between groups at 12 
months adjusted for baseline, site and SIMD.29 Weight 
will be measured to the closest 100 g, in light indoor 
clothing and without shoes, heavy jewellery or pocket 
contents, using regularly calibrated electronic scales. 
Physical activity will be objectively measured using thigh 
worn activPAL accelerometers. These monitors measure 
free-living sedentary, upright and ambulatory activity 
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and provide data on step count and time spent seden-
tary. The devices will be fitted by the research nurses to 
ensure correct placement, and the participants will be 
asked to wear them at all times (excluding when swim-
ming or bathing) for eight nights to ensure a full seven 
days of recording. A demonstration and instructions will 
be provided in case removal is required.
Secondary outcomes
Secondary outcomes will be changes in waist circum-
ference, modes (types) of physical activity, sedentary 
behaviour, eating habits, alcohol intake, psychosocial vari-
ables, economic outcomes, haemoglobin A1c (HbA1c), 
non-fasting lipids and non-fasting insulin, blood pressure 
and cardiovascular disease risk (incorporating blood 
pressure and lipid measures).
Waist circumference will be measured midway between 
the iliac crest and lower costal margin using a Seca 201 
measuring tape. Modes of physical activity will be deter-
mined from a 7-day recall questionnaire,45 and sedentary 
behaviour from analysis of the activPAL data. Ques-
tionnaire-based tools will be used to determine eating 
habits, alcohol intake, psychosocial variables (eg, illness 
perception, knowledge and beliefs about lifestyle and 
breast cancer risk and personal health resources, eg, 
motivation, awareness and social support around weight 
management, self-monitoring and perceived ability to 
manage weight) (table 1). In order to determine the 
economic outcomes of the trial, data on health-related 
quality of life was collected using the EQ-5D-5L question-
naire,42 along with questions on use of NHS healthcare 
resources (number of primary care contacts, inpatient, 
outpatient and day cases).
Blood pressure will be measured using a Microlife 
3BTO digital blood pressure monitor, or other approved 
BP monitor in the local clinical research facility, with the 
participant seated and relaxed. One non-fasted blood 
sample will be taken per person at both the baseline and 
12-month follow-up visits in order to measure HbA1c, 
non-fasting lipids and non-fasting insulin. Samples will 
be processed and stored at local clinical research centres 
and shipped in batches to Glasgow University laborato-
ries for analysis. All samples will be analysed in a blinded 
and anonymised fashion at the same time to minimise 
analytical variation, with no individual results being made 
available to participants.
Delivery outcomes
In addition to the intervention delivery time recording 
and fidelity assessments described earlier, delivery will be 
also be evaluated in terms of engagement (recruitment 
and retention), using data collected by coaches, exit 
Table 1 Outcome measures
Primary outcomes Baseline 12 weeks 12 months
  Body weight Measured using digital body weight scales (kg) X X
  Physical activity 7 days accelerometry with activPAL (steps) X X
Secondary outcomes
  Modes of physical 
activity 
Scottish Physical Activity Screening Questionnaire34 X X X
  Sedentary behaviour 7 days accelerometry with activPAL (subsample only) X X 
  Anthropometric changes Body mass index (height and weight), waist 
circumference (cm)
X X
  Eating habits Questionnaire based on Scottish Health Survey22 X X
  Fruit and vegetable intake39 X
  Alcohol intake Audit C questionnaire40 X X
  Psychosocial variables Modified brief illness questionnaire41 X X
Knowledge and beliefs about lifestyle and breast 
cancer risk (developed in-house) 
X X 
Psychosocial health measures resources (perceived 
motivation, awareness, ability, action, monitoring, and 
social support around weight management) 
X 
Perceived body weight (developed in-house) X X X 
  Economic outcomes EQ-5D-5L questionnaire42 X X X
Economic health resource usage (developed by HERU, 
University of Aberdeen)
X X
  Cardiovascular risk Blood sampling for lipids X X
Blood pressure X X
  Diabetes risk Haemoglobin A1c X X
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questionnaires and through interviews with coaches and 
participants to record their experiences.
Process evaluation
These measures are aimed at identifying feasibility and 
acceptability issues pertinent to decisions about roll-out:
Breast screening centres
 ► Observations from the waiting room by the research 
team will be conducted on two occasions per site 
before and after recruitment commences. Data on 
clinic start and end times will be noted and mammog-
raphy staff asked to provide comments relating to 
clinic flow.
 ► In order to estimate the reach of endorsements by 
mammographers, we will request that clinic numbers 
are obtained (preferably as appointments attended), 
and track total ActWELL cards provided to clinics and 
total cards returned.
 ► A sample of mammographers will be invited to 
participate in individual semi-structured qualita-
tive interviews (one interview per site, total n=4) to 
explore perceptions and experiences of recruitment, 
including perceived ease of study introduction, time 
burden, positive and negative experiences that have 
arisen, handling of questions, support from clinic 
staff and training from research team. Interviews 
will be conducted shortly after the end of the study 
recruitment period (eg, September 2018) to enable 
mammographers to reflect on experiences over the 
whole period while recall is still relatively fresh.
BCN are collecting information on
 ► advertising for coaches (where, when and costs);
 ► responses to advertising (applications and telephone/
email queries);
 ► time and volunteer/coach experience of joint training 
programme with ActWELL team;
 ► volunteer coach reported problems, queries and 
reasons for drop out;
 ► coordinators’ experience of managing coaches.
These data will be used to inform the economic analysis.
BCN lifestyle coaches will be asked to collect data on participant 
contacts
 ► Number of face-to-face visits attended.
 ► Number of phone calls achieved.
 ► Time taken for each contact.
 ► Perceived engagement at each contact.
 ► A sample of coaches from each site (two per site, 
total n=8) will be invited to participate in individual 
semi-structured qualitative interviews to explore 
perceptions and experiences of delivery, including 
recruitment, training, implementation, participant 
contact procedures, perception of intervention 
acceptability, time commitments and exit strategies. 
The interviews will also explore coaches’ perceptions 
of facilitators and barriers to participant engagement 
in the programmes. Interviews will be conducted 
shortly after the end of the delivery period.
Leisure centres
 ► A sample of four leisure centre coordinators will be 
invited to participate in individual semi-structured 
qualitative interviews to explore their perceptions and 
experiences of hosting the coach sessions, including 
burden, space, time, challenges and any potential 
benefits or negative consequences for the leisure 
centre. Interviews will be conducted shortly after the 
end of the delivery period (eg, May 2019) to enable 
coordinators to reflect on experiences over the whole 
period while recall is still relatively fresh.
Participants
Semi-structured qualitative interviews will be conducted 
with 20 intervention participants (5 per study site) after 
expression of an interest to participate during the final 
12-month visit. Interviews will be conducted via tele-
phone. Interviews will be conducted at the end of each 
participant’s period of engagement in the study to allow 
participants to reflect over the entire period of their 
engagement while recall is still relatively fresh. We decided 
not to interview participants during their engagement 
in the study so as to avoid introducing any intervention 
effects which might have arisen from participants being 
sensitised to the questions and issues under discussion.
A semi-structured interview schedule designed to cover 
key topics while also eliciting additional participant 
perspectives will be used. Interviews will cover partici-
pants’ views and experiences of engaging with the study, 
including motives for participation and understanding 
of the study purpose; possible impact of the study on 
attendance for screening; perceptions and opinions of 
the programme content, duration, accessibility inten-
sity, recruitment and exit strategy; views of the coaching 
process and experience of setting goals; experiences of 
attempting to make changes over the 12-month interven-
tion period, and the facilitators and barriers to making 
changes. Possible facilitators and barriers to be explored 
include personal beliefs, motivation, family members, 
social and coach support. With the consent of partici-
pants, all interviews will be audio-recorded.
stAtIstICAl ConsIdErAtIons
sample size
Body weight: using the data from the overweight women 
(BMI >25 kg/m2) in the ActWELL feasibility study (mean 
body weight 80.9±17.9 kg), a total of 414 women (207 per 
group) would be needed to detect a 7% wt change at 90% 
power. Allowing for 25% drop out (based on our findings 
from the feasibility study), this would mean randomising 
552 women. Based on feasibility data, we estimate that 
we would need 849 women to express an interest in the 
study which allows for 25% who would be ineligible on 
grounds of BMI <25 kg/m2 and 10% who initially express 
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interest then change their minds. The NHSSBSP screens 
thousands of women each year so we do not anticipate 
any problems with 849 women expressing an interest in 
the study.
Physical activity: given that the activity data from the 
ActWELL feasibility study was based on self-report, an 
objective measurement of steps using pedometers in the 
predominantly (80%) female participants of the ‘Walking 
for Well-being in the West’ study45 was used to inform the 
sample size calculation. At baseline, a mean of 6802±3212 
steps were recorded in the intervention group. In order 
to detect a difference of 2000 steps between groups at 
follow-up, at 90% power, 102 women (51 per group) 
would be required to complete this aspect of the study 
using activPAL accelerometers (shown to be feasible in 
studies of older adults and enabling accurate estimates of 
activity and sedentary behaviour46 47). Allowing for 20% 
drop out plus any equipment malfunction/postal losses, 
we would recruit a further 30% bringing the total enrol-
ment to 146 of the 552 participants for this aspect of the 
study. In summary, a subsample of 146 of the 552 women 
recruited above will be asked to wear the accelerometers.
Quantitative analysis
Statistical analysis of outcomes will be undertaken by 
statisticians at TCTU. In the main analysis, we will use an 
intention-to-treat analysis with all available data. We will 
undertake multiple linear regression analyses with mixed 
effects models adjusted for the corresponding baseline 
values with group allocation and site as fixed effects. For 
the primary outcomes, we will also undertake a sensi-
tivity analysis using both repeated measures and multiple 
imputations for missing values.
We do not anticipate that clustering effects will be 
a substantial issue in ActWELL, which is why we have 
designed the trial as individually randomised. We antic-
ipate 24 or more BCN lifestyle coaches delivering the 
intervention, making each cluster small at around 10 
participants. It is possible that even more lifestyle coaches 
will be involved depending on the capacity of BCN. We 
also anticipate that participants will be evenly distrib-
uted across the four breast screening centres rather than 
having a dominant centre. We will, however, look for 
evidence of clustering effects as a secondary analysis and 
present and interpret our results in light of this analysis.
Missing data
The extent of missing data will be examined and, if 
necessary, methods such as multiple imputation will be 
implemented to provide robust results, assuming data are 
missing at random (MAR). We will examine the extent of 
missing data by considering the differences between those 
with complete data and those with missing data, and if they 
are similar we will assume data are missing completely at 
random. If they do differ we will assume MAR and use 
multiple imputations and compare with the primary anal-
ysis. We will try to obtain reasons for missing data during 
the trial and if the probability of missing data are related 
to the outcome then data may not be missing at random. 
If this looks likely, then mechanisms of missingness and 
outcomes will be modelled together.
Qualitative analysis
All interview recordings will be transcribed in full for anal-
ysis. Transcripts will be coded for thematic analysis, with 
the coding themes to be agreed among the researchers 
based on the core questions and topic areas, including any 
new and emerging themes. The reliability of the themes 
will then be reassessed by a process of familiarisation with 
the transcript texts. Discussions between researchers will 
enable identification of emerging themes and resolution 
of interpretive difference.
Cost-effectiveness analysis
Intervention costs data will be collected by health 
economics team including:
 ► BCN costs (coordinator salary, training, transport);
 ► Intervention consumable costs (training packs and 
participant materials);
 ► Intervention delivery staff costs (coach training, 
mentoring and overseeing costs).
The cost-effectiveness analysis of the ActWELL inter-
vention compared with usual care will be based on 
resource use and outcomes (EQ-5D-5L) data42 (collected 
from participants’ questionnaires and telephone inter-
views). This will take the format of a within-trial cost-effec-
tiveness analysis and use a cost-utility analysis framework. 
The effects of the ActWELL intervention will be esti-
mated as gain in quality-adjusted life years (QALYs) at 
12 months using EQ-5D-5L data collected at baseline, 
3 and 12 months. Estimates of cost-effectiveness will be 
expressed as the incremental cost per QALY gained (over 
12 months).
Patient and public involvement
The development of research questions and outcome 
measures arose from pilot work,27 which included feed-
back from participants. A public advisory group was 
established comprising three patient representatives 
from breast screening attendees recruited by BCN, plus 
a patient advisor on the investigation team (who will 
chair the public advisory group). The public advisory 
group will be involved in every aspect of the trial. This 
is particularly important with respect to trial design and 
feedback, issues including inequalities, access to inter-
vention, recruitment, perspectives on written, verbal 
and e-communications, burden of study procedures 
(including questionnaires), interpretation of qualitative 
data, conduct of the study and dissemination events. In 
addition, information attained from formative research 
with screening participants will be used to assist in the 
design of the intervention content and delivery. After the 
study is complete, participants will be interviewed to gain 
insight into the study burden and procedures. A summary 
of results will be available for all participants.
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Ethics and dissemination
The ActWELL trial follows all procedures set out by the 
Tayside clinical trials unit including reporting adverse and 
serious adverse events. All reports will be reviewed by the 
senior clinician and appropriate actions taken. The inter-
vention is considered low risk and all coaches are trained 
on supporting modest changes in physical activity to 
decrease risks associated with vigorous or intense activity.
The study dissemination plan includes reports to the 
funder to assist in decision making about potential roll 
out. Reports of the findings will also be shared with 
BCN, Scottish Screening Committee, Scottish Cancer 
Task Force, participating screening centres, participating 
leisure centres and our public advisory group. A summary 
of findings will be available for all participants.
Academic dissemination through papers in peer-re-
viewed journals and conference presentations will be 
focused on reporting the main impact of the inter-
vention on primary and secondary outcomes, health 
economic evaluation and qualitative findings that will 
assist decisions about roll out. Findings related to recruit-
ment challenges, the experience of volunteer coaches 
and psychosocial findings which may have impacted on 
process and outcomes will also be reported.
Public dissemination will use social media chan-
nels including those of the Scottish Cancer Prevention 
Network, academic institutions involved and public 
events such as ‘café science’.
dIsCussIon
This paper describes the protocol for a randomised 
controlled trial to determine the effectiveness and cost-ef-
fectiveness of a weight management intervention targeted 
at women aged between 50 and 70 years of age who are 
invited to attend routine breast screening clinics. This is 
consistent with the concept that ‘every healthcare contact 
is a health improvement opportunity’ as embodied within 
NHS Scotland’s health promoting health service.48
Current epidemiological evidence highlights adult 
weight gain, excess body fat, low levels of physical activity 
and alcohol intake as modifiable factors associated with 
an increased risk of developing postmenopausal breast 
cancer.3 The NHS breast screening setting is one of only 
a few nationwide opportunities that offers face-to-face 
contact by a health professional to over 70% of (healthy) 
women aged 50–70 years including significant numbers 
of women from deprived areas (>60% of women from 
SIMD quintile 1 and >70% from quintile 2)26 who may 
have no other opportunity to access free, personalised 
lifestyle change support. Few other free, national NHS 
clinical services provide a routine invitation to reach 
this number of women in this age group. At present, no 
support for lifestyle change is provided in this setting, 
although survey and intervention work highlights the 
potential for engagement and behaviour change.19 28 
Recent work undertaken in Scotland in routine breast 
screening clinics has reported that a simple women’s 
magazine intervention about breast cancer risk produced 
by The Scottish Cancer Prevention Network resulted in 
60% of respondents claiming an increased knowledge 
about breast cancer, lifestyle and motivation to find out 
more about cancer prevention with 40% of respondents 
expressing intentions to make lifestyle changes.49 It was 
notable that there was no difference in results by social 
position. While concerns have been raised about the 
potential for increasing health inequalities through indi-
vidual level interventions, a recent Cochrane review has 
reported that individual obesity management interven-
tions (in both children and adults) do not increase health 
inequalities.50
While the current trial has primary outcomes of 
increased physical activity and weight loss, the programme 
will target energy expenditure (caloric usage in physical 
activity) and dietary intake (caloric intake from foods, soft 
and alcoholic drinks). The length of the study is designed 
to embrace the principles of weight loss and weight loss 
maintenance and therefore has the potential to achieve a 
long-term change in lifestyle habits. The study has been 
developed from a well-conducted feasibility trial with 
positive indicative outcomes and uses a gold standard 
multicentre, randomised controlled design methodology. 
The development of the intervention used a unique 
combination of staff from academia, NHS, breast cancer 
charity and healthy screening attendees and employs a 
novel approach to deliver weight management by volun-
teers in community locations. The study is not powered 
to assess long-term risk of breast cancer and indeed the 
intervention would need to demonstrate effective weight 
loss prior to investment in a cancer outcomes trial. There 
have been no trials of primary prevention of breast cancer 
using a weight management intervention (largely due to 
length of follow-up and study size). However, there are a 
number of ongoing trials of weight management inter-
ventions in women with a breast cancer diagnosis which 
will report on cancer and all-cause mortality end points 
(as described by Demark-Wahnefried et al51).
It should be noted that the trial is also designed to 
collect information relevant for clinicians and policy-
makers responsible for considerations about the potential 
roll out of the programme throughout the national NHS 
breast screening programme drawing on feedback from 
screening staff and participants. This trial is highlighted 
within the National Cancer Strategy as an investment 
from Scottish government in cancer prevention.52 The 
programme may also have salience internationally where 
population-based breast cancer screening programmes 
are offered.
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